Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 11 | 2025 | 214 | 3.220 |
Why?
|
| Laparoscopy | 11 | 2023 | 520 | 3.180 |
Why?
|
| Bariatric Surgery | 8 | 2025 | 143 | 2.000 |
Why?
|
| Pediatric Obesity | 7 | 2025 | 413 | 1.900 |
Why?
|
| Esophageal Atresia | 4 | 2024 | 53 | 1.360 |
Why?
|
| Moyamoya Disease | 3 | 2022 | 42 | 1.300 |
Why?
|
| Cerebral Revascularization | 3 | 2022 | 22 | 1.250 |
Why?
|
| Gastrectomy | 7 | 2025 | 103 | 1.220 |
Why?
|
| Communication Barriers | 2 | 2015 | 42 | 0.920 |
Why?
|
| Funnel Chest | 1 | 2024 | 33 | 0.830 |
Why?
|
| Omentum | 3 | 2022 | 48 | 0.770 |
Why?
|
| Patient Satisfaction | 2 | 2015 | 490 | 0.720 |
Why?
|
| Physician-Patient Relations | 2 | 2015 | 448 | 0.710 |
Why?
|
| Gastroschisis | 3 | 2017 | 56 | 0.690 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2024 | 194 | 0.670 |
Why?
|
| Endoscopy | 2 | 2024 | 287 | 0.670 |
Why?
|
| Sutures | 2 | 2017 | 68 | 0.620 |
Why?
|
| Respiratory System Abnormalities | 1 | 2018 | 44 | 0.580 |
Why?
|
| Surgical Flaps | 2 | 2022 | 197 | 0.580 |
Why?
|
| Pilomatrixoma | 1 | 2018 | 5 | 0.580 |
Why?
|
| Hair Diseases | 1 | 2018 | 13 | 0.580 |
Why?
|
| Facial Neoplasms | 1 | 2018 | 22 | 0.560 |
Why?
|
| Pancreatic Neoplasms | 3 | 2009 | 739 | 0.560 |
Why?
|
| Retrospective Studies | 22 | 2025 | 17579 | 0.560 |
Why?
|
| Hirschsprung Disease | 1 | 2017 | 38 | 0.560 |
Why?
|
| Hernia, Inguinal | 2 | 2015 | 45 | 0.550 |
Why?
|
| Dermoid Cyst | 1 | 2018 | 34 | 0.550 |
Why?
|
| Ileostomy | 1 | 2017 | 31 | 0.550 |
Why?
|
| Herniorrhaphy | 2 | 2015 | 83 | 0.540 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2017 | 7 | 0.540 |
Why?
|
| Suture Techniques | 2 | 2015 | 188 | 0.530 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 89 | 0.530 |
Why?
|
| Adolescent | 23 | 2025 | 20646 | 0.530 |
Why?
|
| Tracheoesophageal Fistula | 3 | 2023 | 49 | 0.520 |
Why?
|
| Language | 2 | 2015 | 222 | 0.510 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 298 | 0.510 |
Why?
|
| Surgical Procedures, Operative | 2 | 2015 | 192 | 0.500 |
Why?
|
| Birth Weight | 2 | 2017 | 356 | 0.500 |
Why?
|
| Treatment Outcome | 20 | 2025 | 13103 | 0.490 |
Why?
|
| Ligation | 2 | 2015 | 138 | 0.490 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 40 | 0.480 |
Why?
|
| Intestine, Small | 1 | 2017 | 317 | 0.470 |
Why?
|
| Culturally Competent Care | 1 | 2015 | 51 | 0.460 |
Why?
|
| Lung Diseases | 1 | 2018 | 407 | 0.450 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 429 | 0.440 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1096 | 0.420 |
Why?
|
| Humans | 49 | 2025 | 134196 | 0.410 |
Why?
|
| Venous Cutdown | 1 | 2013 | 2 | 0.410 |
Why?
|
| Choledochal Cyst | 1 | 2013 | 9 | 0.410 |
Why?
|
| General Surgery | 1 | 2015 | 220 | 0.400 |
Why?
|
| Jugular Veins | 1 | 2013 | 78 | 0.400 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2013 | 105 | 0.390 |
Why?
|
| Liver | 1 | 2020 | 1876 | 0.380 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2204 | 0.380 |
Why?
|
| Gastric Bypass | 2 | 2023 | 82 | 0.370 |
Why?
|
| Male | 30 | 2025 | 66197 | 0.370 |
Why?
|
| Lung | 2 | 2019 | 1578 | 0.370 |
Why?
|
| Child | 20 | 2025 | 25917 | 0.360 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 139 | 0.360 |
Why?
|
| Splenectomy | 1 | 2011 | 62 | 0.360 |
Why?
|
| Weight Loss | 4 | 2025 | 518 | 0.340 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 907 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 3868 | 0.330 |
Why?
|
| Body Mass Index | 4 | 2023 | 1722 | 0.330 |
Why?
|
| Female | 31 | 2025 | 72037 | 0.330 |
Why?
|
| Infant, Newborn | 8 | 2019 | 8639 | 0.320 |
Why?
|
| Infant | 10 | 2025 | 13262 | 0.310 |
Why?
|
| Pediatrics | 2 | 2015 | 1221 | 0.300 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2009 | 72 | 0.300 |
Why?
|
| Neuroendocrine Tumors | 1 | 2009 | 60 | 0.290 |
Why?
|
| Splenic Vein | 1 | 2008 | 11 | 0.290 |
Why?
|
| Splenic Artery | 1 | 2008 | 23 | 0.290 |
Why?
|
| Physicians | 1 | 2014 | 641 | 0.280 |
Why?
|
| Short Bowel Syndrome | 1 | 2008 | 66 | 0.280 |
Why?
|
| Pancreatectomy | 1 | 2008 | 152 | 0.270 |
Why?
|
| Spleen | 1 | 2008 | 289 | 0.270 |
Why?
|
| Laparotomy | 1 | 2008 | 143 | 0.270 |
Why?
|
| Parenteral Nutrition | 1 | 2008 | 199 | 0.260 |
Why?
|
| Ultrasonography | 3 | 2017 | 1004 | 0.260 |
Why?
|
| Neuroblastoma | 2 | 2022 | 551 | 0.250 |
Why?
|
| Prospective Studies | 7 | 2025 | 6612 | 0.240 |
Why?
|
| Child, Preschool | 12 | 2022 | 14897 | 0.240 |
Why?
|
| Appendicitis | 2 | 2017 | 130 | 0.240 |
Why?
|
| Follow-Up Studies | 7 | 2023 | 5465 | 0.230 |
Why?
|
| Basal Metabolism | 1 | 2025 | 95 | 0.230 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2025 | 60 | 0.230 |
Why?
|
| Intestines | 1 | 2008 | 614 | 0.220 |
Why?
|
| Magnets | 1 | 2024 | 23 | 0.210 |
Why?
|
| Intestinal Atresia | 2 | 2017 | 20 | 0.210 |
Why?
|
| Fluoroscopy | 1 | 2024 | 99 | 0.210 |
Why?
|
| Acetates | 1 | 2023 | 79 | 0.200 |
Why?
|
| Postoperative Complications | 6 | 2023 | 3170 | 0.200 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2022 | 12 | 0.200 |
Why?
|
| Glucocorticoids | 1 | 2025 | 401 | 0.190 |
Why?
|
| Esophagoplasty | 1 | 2022 | 13 | 0.190 |
Why?
|
| Leiomyomatosis | 1 | 2022 | 8 | 0.190 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2022 | 15 | 0.190 |
Why?
|
| Biliary Atresia | 1 | 2025 | 206 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1419 | 0.180 |
Why?
|
| Rectal Fistula | 1 | 2021 | 4 | 0.180 |
Why?
|
| Anus, Imperforate | 1 | 2021 | 20 | 0.180 |
Why?
|
| Urethral Diseases | 1 | 2021 | 19 | 0.180 |
Why?
|
| Urinary Fistula | 1 | 2021 | 20 | 0.180 |
Why?
|
| Diverticulum | 1 | 2021 | 30 | 0.180 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2021 | 53 | 0.170 |
Why?
|
| Intraoperative Period | 1 | 2020 | 74 | 0.160 |
Why?
|
| Energy Metabolism | 1 | 2025 | 814 | 0.160 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2019 | 20 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 90 | 0.160 |
Why?
|
| Intraoperative Care | 1 | 2020 | 120 | 0.160 |
Why?
|
| Telomerase | 1 | 2020 | 179 | 0.150 |
Why?
|
| Preoperative Period | 1 | 2018 | 93 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 1416 | 0.140 |
Why?
|
| Eyebrows | 1 | 2018 | 13 | 0.140 |
Why?
|
| Forehead | 1 | 2018 | 13 | 0.140 |
Why?
|
| Epidermal Cyst | 1 | 2018 | 18 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2021 | 246 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2021 | 1493 | 0.140 |
Why?
|
| Cerebellar Neoplasms | 1 | 2022 | 461 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2018 | 133 | 0.140 |
Why?
|
| Young Adult | 7 | 2021 | 9961 | 0.140 |
Why?
|
| Pylorus | 1 | 2017 | 21 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2018 | 148 | 0.130 |
Why?
|
| Medulloblastoma | 1 | 2022 | 571 | 0.130 |
Why?
|
| Fundoplication | 1 | 2017 | 70 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2019 | 360 | 0.130 |
Why?
|
| Cicatrix | 1 | 2018 | 128 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 2170 | 0.130 |
Why?
|
| Diaphragm | 1 | 2017 | 99 | 0.130 |
Why?
|
| Prevalence | 2 | 2021 | 2684 | 0.130 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2016 | 28 | 0.120 |
Why?
|
| Biopsy | 1 | 2020 | 1303 | 0.120 |
Why?
|
| Patient Selection | 1 | 2020 | 734 | 0.120 |
Why?
|
| Gestational Age | 2 | 2017 | 1230 | 0.120 |
Why?
|
| Testicular Hydrocele | 1 | 2015 | 3 | 0.120 |
Why?
|
| Dissection | 1 | 2016 | 58 | 0.120 |
Why?
|
| Gastroscopy | 1 | 2016 | 102 | 0.120 |
Why?
|
| Telemedicine | 1 | 2022 | 507 | 0.120 |
Why?
|
| Time Factors | 3 | 2021 | 6595 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 709 | 0.120 |
Why?
|
| Hamartoma | 1 | 2016 | 53 | 0.120 |
Why?
|
| California | 1 | 2015 | 144 | 0.120 |
Why?
|
| Gastric Fistula | 1 | 2014 | 5 | 0.120 |
Why?
|
| Angiography | 1 | 2015 | 215 | 0.120 |
Why?
|
| Home Childbirth | 1 | 2015 | 39 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 99 | 0.110 |
Why?
|
| Maternal Age | 1 | 2015 | 141 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2020 | 5219 | 0.110 |
Why?
|
| Cutaneous Fistula | 1 | 2014 | 23 | 0.110 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 115 | 0.110 |
Why?
|
| Quality Improvement | 2 | 2023 | 700 | 0.110 |
Why?
|
| Hematoma | 1 | 2015 | 94 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2015 | 294 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 771 | 0.110 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 365 | 0.110 |
Why?
|
| United States | 4 | 2021 | 11798 | 0.110 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 633 | 0.110 |
Why?
|
| Gastrostomy | 1 | 2014 | 92 | 0.110 |
Why?
|
| Infant Mortality | 1 | 2015 | 180 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2318 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 85 | 0.100 |
Why?
|
| Length of Stay | 3 | 2025 | 1393 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2018 | 780 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 680 | 0.100 |
Why?
|
| Adult | 9 | 2021 | 31948 | 0.100 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 244 | 0.100 |
Why?
|
| Developing Countries | 1 | 2015 | 289 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 7239 | 0.100 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 493 | 0.100 |
Why?
|
| Anastomosis, Surgical | 2 | 2023 | 165 | 0.100 |
Why?
|
| Thoracic Neoplasms | 1 | 2012 | 38 | 0.100 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 278 | 0.090 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2017 | 422 | 0.090 |
Why?
|
| Thoracic Wall | 1 | 2012 | 40 | 0.090 |
Why?
|
| Surgical Mesh | 1 | 2012 | 72 | 0.090 |
Why?
|
| Hypertension | 1 | 2021 | 1407 | 0.090 |
Why?
|
| Middle Aged | 5 | 2021 | 29414 | 0.090 |
Why?
|
| Umbilicus | 1 | 2011 | 14 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 127 | 0.090 |
Why?
|
| Obesity | 2 | 2021 | 2448 | 0.090 |
Why?
|
| Recurrence | 1 | 2015 | 1470 | 0.090 |
Why?
|
| Wound Healing | 1 | 2015 | 489 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 316 | 0.090 |
Why?
|
| Reoperation | 3 | 2025 | 851 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 330 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1854 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2015 | 857 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2020 | 2735 | 0.080 |
Why?
|
| Pregnancy | 2 | 2019 | 7600 | 0.080 |
Why?
|
| Enterostomy | 1 | 2008 | 6 | 0.070 |
Why?
|
| Nebraska | 1 | 2008 | 1 | 0.070 |
Why?
|
| Intestinal Volvulus | 1 | 2008 | 40 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2008 | 129 | 0.070 |
Why?
|
| Age of Onset | 1 | 2008 | 638 | 0.060 |
Why?
|
| Diphosphonates | 1 | 2006 | 43 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 59 | 0.060 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 56 | 0.060 |
Why?
|
| Aged | 3 | 2009 | 21805 | 0.060 |
Why?
|
| Calorimetry, Indirect | 1 | 2025 | 61 | 0.060 |
Why?
|
| Cholangitis | 1 | 2025 | 40 | 0.060 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2008 | 248 | 0.060 |
Why?
|
| Carotid Stenosis | 1 | 2006 | 135 | 0.060 |
Why?
|
| Cerebral Palsy | 1 | 2006 | 86 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2025 | 1735 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2025 | 206 | 0.060 |
Why?
|
| Adrenal Gland Diseases | 1 | 2004 | 16 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 394 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2025 | 401 | 0.050 |
Why?
|
| Emergency Service, Hospital | 3 | 2017 | 1165 | 0.050 |
Why?
|
| Compassionate Use Trials | 1 | 2023 | 15 | 0.050 |
Why?
|
| Cysts | 1 | 2004 | 104 | 0.050 |
Why?
|
| Accreditation | 1 | 2023 | 94 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2022 | 79 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2022 | 151 | 0.050 |
Why?
|
| Body Composition | 1 | 2025 | 564 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2025 | 430 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 49 | 0.040 |
Why?
|
| Nutrition Disorders | 1 | 2021 | 32 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2004 | 519 | 0.040 |
Why?
|
| Indolizines | 1 | 2020 | 3 | 0.040 |
Why?
|
| Remission Induction | 1 | 2021 | 310 | 0.040 |
Why?
|
| Incidence | 1 | 2008 | 3424 | 0.040 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2020 | 3 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 2020 | 23 | 0.040 |
Why?
|
| Stents | 1 | 2006 | 881 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 29 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 76 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 43 | 0.040 |
Why?
|
| Pyridazines | 1 | 2020 | 54 | 0.040 |
Why?
|
| Risk Factors | 2 | 2015 | 11189 | 0.040 |
Why?
|
| Inpatients | 1 | 2022 | 549 | 0.040 |
Why?
|
| Stroke | 1 | 2006 | 1079 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2020 | 335 | 0.040 |
Why?
|
| Piperazines | 1 | 2020 | 256 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 333 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2022 | 874 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 914 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 1013 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2025 | 1122 | 0.030 |
Why?
|
| Chromatin | 1 | 2020 | 617 | 0.030 |
Why?
|
| Histones | 1 | 2020 | 572 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 1434 | 0.030 |
Why?
|
| Zimbabwe | 1 | 2015 | 11 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1627 | 0.030 |
Why?
|
| Mozambique | 1 | 2015 | 23 | 0.030 |
Why?
|
| Surgery Department, Hospital | 1 | 2015 | 22 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1193 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2016 | 314 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2997 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 189 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 106 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 1008 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 106 | 0.030 |
Why?
|
| Stomach | 1 | 2016 | 272 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 387 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 827 | 0.030 |
Why?
|
| Neoplasms | 1 | 2008 | 3035 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 158 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 1135 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1492 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 609 | 0.020 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2012 | 15 | 0.020 |
Why?
|
| Sarcoma, Synovial | 1 | 2012 | 22 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 3800 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 2137 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1908 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2014 | 278 | 0.020 |
Why?
|
| Sarcoma, Ewing | 1 | 2012 | 116 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1344 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2015 | 519 | 0.020 |
Why?
|
| Premature Birth | 1 | 2015 | 419 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 2163 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 474 | 0.020 |
Why?
|
| Scoliosis | 1 | 2012 | 143 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 225 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3753 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 5084 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 447 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4936 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2006 | 33 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2006 | 162 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 571 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2006 | 207 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2006 | 211 | 0.010 |
Why?
|
| Bone Density | 1 | 2006 | 377 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 19045 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 3226 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 36521 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 3119 | 0.010 |
Why?
|